Stryker Corporation (SYK) : Iab Financial Bank reduced its stake in Stryker Corporation by 1.6% during the most recent quarter end. The investment management company now holds a total of 33,884 shares of Stryker Corporation which is valued at $4,146,046 after selling 550 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Jul 18, 2016.Stryker Corporation makes up approximately 2.54% of Iab Financial Bank’s portfolio.
Other Hedge Funds, Including , Barrett Asset Management reduced its stake in SYK by selling 1,990 shares or 0.83% in the most recent quarter. The Hedge Fund company now holds 238,026 shares of SYK which is valued at $29,124,861. Stryker Corporation makes up approx 2.43% of Barrett Asset Management’s portfolio. Stuart Chaussee Associates sold out all of its stake in SYK during the most recent quarter. The investment firm sold 65 shares of SYK which is valued $7,963.Forte Capital Adv reduced its stake in SYK by selling 675 shares or 4.49% in the most recent quarter. The Hedge Fund company now holds 14,346 shares of SYK which is valued at $1,757,528. Stryker Corporation makes up approx 0.66% of Forte Capital Adv’s portfolio.
Stryker Corporation opened for trading at $122.3 and hit $122.65 on the upside on Wednesday, eventually ending the session at $122.36, with a gain of 0.49% or 0.6 points. The heightened volatility saw the trading volume jump to 12,97,449 shares. Company has a market cap of $45,760 M.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.